Brief: Bcal Diagnostics Appoints Anne-Louise Arnett As CEO
May 11 (Reuters) - BCAL Diagnostics Ltd BDX.AX: BCAL APPOINTS ANNE-LOUISE ARNETT AS CHIEF EXECUTIVE OFFICER APPOINTS ANNE-LOUISE ARNETT AS CEO EFFECTIVE JUNE 1, 2026 Further company coverage: BDX.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on BCAL Diagnostics
See all newsBrief: Bcal Diagnostics Secures A$4.9 Million Under Convertible Note Facility
Australia's BCAL Diagnostics soars on development of new blood test for breast cancer
Brief: BCAL Diagnostics Says Validation Agreement Signed With Sonic USA, For Breastest V2
Australia's BCAL Diagnostics launches early detection cancer platform, shares rise
Brief: BCAL Diagnostics Launches Early Detection Cancer Platform